secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2026-06-03T10:47:08+00:00
Accession:  0001628280-26-040034
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q4 rev $9.8B (+6.6% organic), non-GAAP EPS $1.55; dividend raised to $0.72
--------------------------------------------------------------------------------

- Q4 revenue $9.807B, +9.9% reported / +6.6% organic; GAAP EPS $0.96, non-GAAP EPS $1.55.
- FY26 revenue $36.364B, +8.4% reported / +5.8% organic; GAAP EPS $3.73, non-GAAP EPS $5.53.
- Dividend increased to $0.72/quarter ($2.88 annual), payable July 17, 2026; 49th consecutive annual increase.
- FY27 guidance: organic revenue growth 6.75%-7.25%, non-GAAP EPS $5.90-$6.00.
- Cardiac Ablation Solutions revenue +78% globally; Hugo RAS submission filed with FDA for general surgery/gyn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000162828026040034/0001628280-26-040034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000162828026040034/mdt-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-040034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer